Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study
In this study highlighting the French experience for the use of CP in LT patients, we observed a limited, heterogenous but well-tolerated use of this therapy.
Authors
- Olivier Collange (ORCID: https://orcid.org/0000-0003-4169-1517)
- Thomas Villeneuve (ORCID: https://orcid.org/0000-0002-1947-3401)
- A.P. Chaudhry (ORCID: https://orcid.org/0000-0003-3702-1115)
- Benjamin Renaud‐Picard (ORCID: https://orcid.org/0000-0003-3492-9486)
- Floriane Gallais (ORCID: https://orcid.org/0000-0001-9727-9391)
- Sylvie Colin de Verdière (ORCID: https://orcid.org/0009-0007-4854-8955)
- Eva Chatron (ORCID: https://orcid.org/0000-0002-8210-1272)
- Pierre‐Emmanuel Falcoz (ORCID: https://orcid.org/0000-0002-5915-5512)
- D. Horeau
- Élodie Blanchard (ORCID: https://orcid.org/0000-0001-5445-9122)
Institutions
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Hospices Civils de Lyon (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- Hôpital Foch (FR)
Publication Details
- Journal
- Respiratory Medicine and Research
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.resmer.2024.101145
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39